Page last updated: 2024-08-26

arsenic and Leukemia, Pre-B-Cell

arsenic has been researched along with Leukemia, Pre-B-Cell in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alikarami, F; Kazemi, A; Teremmahi Ardestanii, M; Toosi, B; Zaker, F	1

Other Studies

1 other study(ies) available for arsenic and Leukemia, Pre-B-Cell

Article	Year
VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 102 Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Morpholines; NF-kappa B; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Purines; TOR Serine-Threonine Kinases	2018

Article

Year

VS-5584 as a PI3K/mTOR inhibitor enhances apoptotic effects of subtoxic dose arsenic trioxide via inhibition of NF-κB activity in B cell precursor-acute lymphoblastic leukemia.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2018, Volume: 102

Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Humans; Morpholines; NF-kappa B; Oxides; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Precursor B-Cell Lymphoblastic Leukemia-Lymphoma; Purines; TOR Serine-Threonine Kinases

2018